eXoZymes (EXOZ)
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for syn...
- Open
- 8.010
- High
- 8.010
- Low
- 7.080
- Prev. Close
- 7.040
- Volume
- 10.23K
- Turnover
- 76.18K
- Avg Price
- 7.445
- Bid/Ask Ratio
- --
- Amplitude
- 13.21%
- 52wk High
- 18.400
- Volume Ratio
- 0.77
- Turnover Ratio
- 0.14%
News
- benzinga_article · 2 days ago, 04:06 PM
12 Health Care Stocks Moving In Thursday's After-Market Session
- Quartr · 2 days ago, 03:16 PM
EXOZ: NCT program exceeded targets; $6M raised and $2M NIH grant secured for R&D and commercialization
- TradingView · Aug 13 at 02:51 PM
EXOZYMES INC. 2Q 2026: Revenue $0 Net loss $(5.25M) — 10-Q Summary
- PUBT · Aug 13 at 02:50 PM
Exozymes FY26 Q2 net loss widens 22% to $2.88 million; revenue remains no revenue
- PUBT · Aug 11 at 03:21 PM
eXoZymes menjadwalkan konferensi pers kuartal II 2026 lewat webinar
- TradingView · Jul 1 at 03:33 PM
eXoZymes Raises $0.64 Million Via Unit Offering; Adds MDB Placement Pact and Warrant Coverage
